{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:05:01Z","timestamp":1788354301064,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Temporal lobe epilepsy (TLE) is the most common type of focal epilepsy in adults. Experimental and clinical data indicate that neuroinflammation and neurodegeneration accompanying epileptogenesis make a significant contribution to the chronicity of epilepsy and the development of drug resistance in TLE cases. Changes in plasma and serum concentrations of proteins associated with neuroinflammation and neurodegeneration can be predictive biomarkers of the course of the disease. This study used an enzyme-linked immunosorbent assay of the following plasma proteins: brain-derived neurotrophic factor (BDNF), tumor necrosis factor alpha (TNFa), and high-mobility group protein B1 (HMGB1) in patients with mesial TLE to search for biomarkers of the disease. The objective of the study was to examine biomarkers of the neuroinflammation and neurodegeneration of plasma: BDNF, TNFa, and HMGB1. The aim of the study was to identify changes in the concentration of circulating pro-inflammatory and neurotrophic factors that are prognostically significant for the development of drug resistance and the course of TLE. A decrease in the concentration of BDNF, TNFa, and HMGB1 was registered in the group of patients with TLE compared with the control group. A significant decrease in the concentration of HMGB1 in patients with drug-resistant TLE was observed. Aberrations in plasma concentrations of BDNF, TNFa, and HMGB1 in patients with TLE compared with the controls have been confirmed by earlier studies. A decrease in the expression of the three biomarkers may be the result of neurodegenerative processes caused by the long course of the disease. The results of the study may indicate the acceptability of using HMGB1 and TNFa as prognostic biological markers to indicate the severity of the disease course and the risk of developing drug resistance.<\/jats:p>","DOI":"10.3390\/metabo13010083","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:31:44Z","timestamp":1672810304000},"page":"83","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults"],"prefix":"10.3390","volume":"13","author":[{"given":"Yulia S.","family":"Panina","sequence":"first","affiliation":[{"name":"Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E.","family":"Timechko","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-6719","authenticated-orcid":false,"given":"Anna A.","family":"Usoltseva","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-5830","authenticated-orcid":false,"given":"Kristina D.","family":"Yakovleva","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kantimirova","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4639-6365","authenticated-orcid":false,"given":"Diana V.","family":"Dmitrenko","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1535-7511.2005.00059.x","article-title":"Temporal Lobe Epilepsy: More than Hippocampal Pathology","volume":"5","author":"Cascino","year":"2005","journal-title":"Epilepsy Curr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.seizure.2014.03.003","article-title":"Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis","volume":"23","author":"Centanaro","year":"2014","journal-title":"Seizure"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/ane.12669","article-title":"Effective connectivity in temporal lobe epilepsy with hippocampal sclerosis","volume":"135","author":"Park","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/nan.12458","article-title":"Review: Neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: Clinical, pathological and neuroimaging evidence","volume":"44","author":"Tai","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(15)00383-X","article-title":"Brain imaging in the assessment for epilepsy surgery","volume":"15","author":"Duncan","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/epi.14505","article-title":"The expression of inflammatory markers and their potential influence on efflux transporters in drug-resistant mesial temporal lobe epilepsy tissue","volume":"59","author":"Weidner","year":"2018","journal-title":"Epilepsia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.seizure.2021.07.028","article-title":"Temporal lobe epilepsy: Evaluation of central and systemic immune-inflammatory features associated with drug resistance","volume":"91","author":"Toledo","year":"2021","journal-title":"Seizure"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/epi.16688","article-title":"Blood and cerebrospinal fluid immune cell profiles in patients with temporal lobe epilepsy of different etiologies","volume":"61","author":"Langenbruch","year":"2020","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nbd.2008.05.007","article-title":"Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1\u03b2 production","volume":"31","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain Inflammation in Epilepsy: Experimental and Clinical Evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbadis.2019.01.026","article-title":"Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E","volume":"1865","author":"Ambrogini","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wolinski, P., Ksiazek-Winiarek, D., and Glabinski, A. (2022). Cytokines and Neurodegeneration in Epileptogenesis. Brain Sci., 12.","DOI":"10.3390\/brainsci12030380"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/2020.7.JNS20284","article-title":"Resective temporal lobe surgery in refractory temporal lobe epilepsy: Prognostic factors of postoperative seizure outcome","volume":"135","author":"Borger","year":"2021","journal-title":"J. Neurosurg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14412\/2074-2711-2018-1S-38-45","article-title":"The role of neuroinflammation in the pathogenesis of epilepsy","volume":"10","author":"Lipatova","year":"2018","journal-title":"Neurol. Neuropsychiatry Psychosom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","article-title":"Past and Present Definitions of Epileptogenesis and Its Biomarkers","volume":"11","author":"Engel","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1515\/joepi-2016-0010","article-title":"The medial temporal lobe epilepsy is a bilateral disease\u2014novel aspects","volume":"24","year":"2016","journal-title":"J. Epileptol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"107742","DOI":"10.1016\/j.neuropharm.2019.107742","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","volume":"167","author":"Terrone","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2010.06.002","article-title":"Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: Uncontrolled inflammation drives disease progression?","volume":"296","author":"Yang","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2018.05.007","article-title":"Epilepsy biomarkers\u2014Toward etiology and pathology specificity","volume":"123","author":"Lapinlampi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cao, M.C., Cawston, E.E., Chen, G., Brooks, C., Douwes, J., McLean, D., Graham, E.S., Dragunow, M., and Scotter, E.L. (2022). Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02730-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11011-021-00847-9","article-title":"Promissing protein biomarkers in the early diagnosis of Alzheimer\u2019s disease","volume":"34","author":"Sharma","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yakovleva, K.D., Dmitrenko, D.V., Panina, I.S., Usoltseva, A.A., Gazenkampf, K.A., Konovalenko, O.V., Kantimirova, E.A., Novitsky, M.A., Nasyrova, R.F., and Shnayder, N.A. (2022). Expression Profile of miRs in Mesial Temporal Lobe Epilepsy: Systematic Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020951"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/NDT.S242766","article-title":"HMGB1\/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly Individuals","volume":"19","author":"Han","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(14)60368-8","article-title":"High mobility group box 1 in the inflammatory pathogenesis of epilepsy: Profiling circulating levels after experimental and clinical seizures","volume":"383","author":"Walker","year":"2014","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s11064-016-2153-0","article-title":"HMGB1-TLR4 Axis Plays a Regulatory Role in the Pathogenesis of Mesial Temporal Lobe Epilepsy in Immature Rat Model and Children via the p38MAPK Signaling Pathway","volume":"42","author":"Yang","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-01825-x","article-title":"Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients","volume":"20","author":"Basnyat","year":"2020","journal-title":"BMC Neurol."},{"key":"ref_31","first-page":"2043","article-title":"Sodium valproate combined with levetiracetam in pediatric epilepsy and its influence on NSE, IL-6, hs-CRP and electroencephalogram improvement","volume":"20","author":"Liu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eplepsyres.2009.05.009","article-title":"Etiology and site of temporal lobe epilepsy influence postictal cytokine release","volume":"86","author":"Bauer","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_33","first-page":"6","article-title":"Immune disorders in patients with epilepsy and the possibility of immunomodulation with recombinant human interleukin IL-2","volume":"6","author":"Lipatova","year":"2014","journal-title":"Epilepsy Paroxysmal Cond."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1172\/JCI92001","article-title":"Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy","volume":"127","author":"Walker","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1684\/epd.2020.1155","article-title":"HMGB-1, TLR4, IL-1R1, TNF-\u03b1, and IL-1\u03b2: Novel epilepsy markers?","volume":"22","author":"Dilber","year":"2020","journal-title":"Epileptic Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000243081","article-title":"Levels of IL-1beta and IL-1RA in cerebrospinal fluid of human patients after single and prolonged","volume":"17","author":"Palmio","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/epi.13387","article-title":"Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen\u2019s encephalitis: An open pilot study","volume":"57","author":"Lagarde","year":"2016","journal-title":"Epilepsia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1742-2094-9-207","article-title":"Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines","volume":"30","author":"Kan","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.expneurol.2013.01.011","article-title":"Opposing actions of hippocampus TNF\u03b1 receptors on limbic seizure susceptibility","volume":"247","author":"Weinberg","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.blre.2020.100711","article-title":"Role of inflammation in the biology of myeloproliferative neoplasms","volume":"42","author":"Koschmieder","year":"2020","journal-title":"Blood Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0074-7742(07)82013-7","article-title":"Cytokines and Neuronal Ion Channels in Health and Disease","volume":"82","author":"Viviani","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1073858405278266","article-title":"To BDNF or Not to BDNF: That Is the Epileptic Hippocampus","volume":"11","author":"Koyama","year":"2005","journal-title":"Neuroscientist"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.0b013e3181f612bb","article-title":"Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures","volume":"75","author":"LaFrance","year":"2010","journal-title":"Neurology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.222550499","article-title":"Antiepileptic drugs and apoptotic neurodegeneration in the developing brain","volume":"99","author":"Bittigau","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0896-6273(02)00942-X","article-title":"Mechanism of TrkB-Mediated Hippocampal Long-Term Potentiation","volume":"36","author":"Minichiello","year":"2002","journal-title":"Neuron"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuroscience.2004.03.044","article-title":"The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes","volume":"126","author":"Xu","year":"2004","journal-title":"Neuroscience"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2011.01.001","article-title":"Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy","volume":"42","author":"Heinrich","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/emmm.201000077","article-title":"High mobility group box-1 recognition: The beginning of a RAGEless era?","volume":"2","author":"Lambrecht","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"ref_49","first-page":"5125","article-title":"HMGB1 mediates microglia activation via the TLR4\/NF-\u03baB pathway in coriaria lactone induced epilepsy","volume":"17","author":"Shi","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"ref_51","first-page":"2928","article-title":"Expression level and distribution of HMGB1 in Sombati\u2019s cell model and kainic acid-induced epilepsy model","volume":"19","author":"Huang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/1\/83\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:58:43Z","timestamp":1760119123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/1\/83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["metabo13010083"],"URL":"https:\/\/doi.org\/10.3390\/metabo13010083","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}